Uricase and other novel agents for the management of patients with treatment-failure gout.
- 20 June 2007
- journal article
- review article
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 9 (3) , 258-264
- https://doi.org/10.1007/s11926-007-0041-y
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Pharmacokinetics and pharmacodynamics of intravenous PEGylated recombinant mammalian urate oxidase in patients with refractory goutArthritis & Rheumatism, 2007
- Successful treatment with rasburicase of a tophaceous gout in a patient allergic to allopurinolNature Clinical Practice Rheumatology, 2006
- IL1RN genotype as a risk factor for joint pain in hereditary haemochromatosis?Annals of the Rheumatic Diseases, 2006
- Human parvovirus B19 viraemia is associated with neither IgM positivity nor anaemia in patients with rheumatic diseasesAnnals of the Rheumatic Diseases, 2006
- Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and GoutNew England Journal of Medicine, 2005
- Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD)Rheumatology, 2005
- Winners of the 2004 American College of Rheumatology Annual Slide CompetitionArthritis & Rheumatism, 2005
- Serum hyaluronan levels and radiographic knee and hip osteoarthritis in African Americans and Caucasians in the Johnston County Osteoarthritis ProjectArthritis & Rheumatism, 2005
- Polyarticular Versus Monoarticular GoutMedicine, 1988
- Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis.Proceedings of the National Academy of Sciences, 1981